-
Product Insights
Retinopathy Of Prematurity - Drugs In Development, 2024
Empower your strategies with our Retinopathy Of Prematurity – Drugs In Development, 2024 report and make more profitable business decisions. Retinopathy of prematurity (ROP) is a disease that affects immature vasculature in the eyes of premature babies. This disorder, which usually develops in both eyes, is one of the most common causes of visual loss in childhood and can lead to lifelong vision impairment and blindness. Risk factors for the development of ROP include prematurity, extremely low birth weight, and multiple...
-
Product Insights
Blepharitis - Drugs In Development, 2024
Empower your strategies with our Blepharitis – Drugs In Development, 2024 report and make more profitable business decisions. Blepharitis is an inflammation of the eyelids, usually caused by an excess growth of bacteria that is ordinarily found on the skin, blockage of the eyelid's oil glands, and occasionally allergies. Blepharitis signs and symptoms include red and watery eyes, itchy eyelids, and sensitivity to light. Treatment includes antibiotics, lubricating eye drops, and steroid eye drops or ointments. The Blepharitis drugs in development...
-
Product Insights
Corneal Dystrophy - Drugs In Development, 2024
Empower your strategies with our Corneal Dystrophy – Drugs In Development, 2024 report and make more profitable business decisions. Corneal dystrophy (CD) is defined as a collection of rare hereditary non-inflammatory disorders of abnormal deposition of substances in the cornea. The material may cause the cornea to lose its transparency and can cause loss of vision or blurred vision. Corneal dystrophies can appear at any age and men and women are equally affected by most corneal dystrophies. The symptoms of corneal...
-
Product Insights
Leber Congenital Amaurosis (LCA) - Drugs In Development, 2024
Empower your strategies with our Leber Congenital Amaurosis (LCA) – Drugs In Development, 2024 report and make more profitable business decisions. Leber congenital amaurosis (LCA) is a genetic eye disorder that primarily affects the retina, which is the specialized tissue at the back of the eye that detects light and color. This condition is the most common cause of inherited blindness in childhood. Symptoms include vision loss, roving eye movements, deep-set eyes, developmental delay, epilepsy, and motor skill impairment. The Leber...
-
Product Insights
Leber’s Hereditary Optic Neuropathy (Leber Optic Atrophy) - Drugs In Development, 2024
Empower your strategies with our Leber's Hereditary Optic Neuropathy (Leber Optic Atrophy) – Drugs In Development, 2024 report and make more profitable business decisions. Leber’s hereditary optic neuropathy (LHON) is an inherited form of vision loss. This condition usually begins in a person's teens or twenties; rare cases may appear in early childhood or later in adulthood. Males are affected much more often than females. Symptoms include eye pain or discomfort, numbness, tingling, and clouding of vision. Predisposing factors include age,...
-
Product Insights
Cataract - Drugs In Development, 2024
Empower your strategies with our Cataract – Drugs In Development, 2024 report and make more profitable business decisions. A cataract is a clouding of the normally clear lens of eye that affects vision. Symptoms include clouded, blurred, or dim vision; increasing difficulty with vision at night; fading or yellowing of colors; double vision in a single eye; and frequent prescription changes in eye wear. Risk factors include age, diabetes, excessive alcohol consumption, high blood pressure, obesity, and smoking. The Cataract drugs...
-
Product Insights
Non-infectious Uveitis - Drugs In Development, 2024
Empower your strategies with our Non-infectious Uveitis – Drugs In Development, 2024 report and make more profitable business decisions. Non-infectious uveitis (NIU) is a group of disorders characterized by intraocular inflammation at different levels of the eye. NIU is a leading cause of irreversible blindness in working-age population in the developed world. Noninfectious uveitis can result from an eye injury or a disease somewhere else in your body. The goal of uveitis treatment is to control inflammation, prevent recurrences, and preserve...
-
Product Insights
Panuveitis - Drugs In Development, 2024
Empower your strategies with our Panuveitis – Drugs In Development, 2024 report and make more profitable business decisions. Panuveitis, or diffuse uveitis, is the inflammation of uveal components of the eye. It is caused by inflammation due to infections, immune-related inflammation, intraocular malignancies like retinoblastoma or iris melanoma, and traumas. Symptoms include pain, redness, watery discharge, photophobia, and edema. Diagnostics tests include blood tests, X-ray, and thorough eye examination, which includes slit-lamp exam, tonometry, and dilated eye exam. The treatment varies...
-
Product Insights
Atopic Keratoconjunctivitis - Drugs In Development, 2024
Empower your strategies with our Atopic Keratoconjunctivitis – Drugs In Development, 2024 report and make more profitable business decisions. Atopic keratoconjunctivitis (AKC) is chronic allergic disease of eye. It is caused by atopy, a genetic condition that causes the immune system to produce more antibodies than normal in response to allergens. Symptoms include sensitivity to light, itching, burning, tearing, and red and hardened eyelids. AKC is usually diagnosed through clinical examination and a medical and family history, although a conjunctival biopsy...
-
Product Insights
Blepharospasm - Drugs In Development, 2024
Empower your strategies with our Blepharospasm – Drugs In Development, 2024 report and make more profitable business decisions. Blepharospasm is involuntary eyelid movements like blinking or twitching. It is caused due to abnormalities in an area of the brain that impacts muscle movement. Symptoms include uncontrollable blink, squint, wink, twitch, or squeezing closed one or both eyes. Diagnosis relies on physical examination, medical history, and ruling out other possible causes. Treatment for blepharospasm can include stress management, botulinum type A toxin...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.